2022-PECO-002: PEPFAR Ethiopia Community-Led Monitoring (CLM) Activities
Closed
This grant is closed. A newer notice from the same program is open now: Advancing Global Health (DFOP0017890). Status: Closes February 14, 2027 (99 days left). It is in our archive of U.S. Mission to Ethiopia notices from 2022.
U.S. Mission to Ethiopia offered grants of up to $24,999 (at least $22,999) to the applicants described in the notice. It expected to make about 12 awards worth $300,000 in total. Applications closed on June 24, 2022.
From the official notice on Grants.gov, last changed May 24, 2022. Checked November 7, 2026.
- Award ceiling$24,999
- Award floor$22,999
- Total funding$300,000
- Expected awards12
- Cost sharingNot required
- Funding typeGrant
Key dates
| Posted | May 25, 2022 |
|---|---|
| Deadline | June 24, 2022 |
| Archived by Grants.gov | July 24, 2022 |
Who can apply
This opportunity was open to the applicants described in the notice.
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Eligible applicants include registered independent and local/community-based organizations, women-led civil society organizations, PLHIV associations, faith-based organizations, and other community-based groups and/or networks whose functions covers HIV programs.
Is this a realistic fit?
- Past The U.S. President's Emergency Plan for AIDS Relief Programs awards averaged $146,897; this notice allows up to $24,999 per award.
- Most of the program's money (74% over five years) went to nonprofits.
- No cost sharing or match is required.
What the grant funds
The U.S. Embassy in Addis Ababa / PEPFAR Ethiopia Coordination Office (PECO) is pleased to announce an open Notice of Funding Opportunity (NOFO) to solicit applications that implement Community-led Monitoring (CLM) activities for its HIV/AIDS programs. The CLM program is funded through the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR). One of PEPFAR’s goals in Ethiopia is to support efforts to achieve HIV epidemic control through the implementation of evidence-based interventions in HIV prevention, care, and treatment and ultimately, save lives. Through the PEPFAR Coordination Office, the U.S. Embassy in Addis Ababa administers this Community Grants Program and is currently seeking proposals from registered local Community-based organizations and other civil society groups, networks of key populations (KP), people living with HIV (PLHIV), women-led civil society organizations and other groups affected by HIV, or community entities that have expertise in gathering quantitative and qualitative data about HIV services, and whose functions covers HIV programs. The CLM activity is key to ensuring the availability of, access to, and delivery of quality HIV prevention, care, and treatment services. The activity will empower clients and communities to seek out information, increase health literacy, expand engagement with the health service, support demand creation for high-quality HIV services, and demand accountability from the health system to improve the quality of these services. The CLM activity will collect data using standardized tools. Quantitative and qualitative data collected through CLM will be synthesized, analyzed, and used to gain insights from communities/beneficiaries about problems, barriers, and potential solutions to HIV services delivery at the facility, community, sub-national and national levels. Results from CLM will be presented and analyzed in collaboration between community representatives, service providers, facility managers and relevant implementing partners to ensure dialogue and help all sides identify service delivery gaps and design solutions collaboratively to improve service delivery, continuity of treatment, and retention in care. PEPFAR-supported community-led monitoring programs must include an explicit focus on key populations or affected populations.
Who has won The U.S. President's Emergency Plan for AIDS Relief Programs grants before
From fiscal 2021 to 2025, The U.S. President's Emergency Plan for AIDS Relief Programs (19.029) awarded $117 million across 794 grant awards, an average of $146,897 per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. | Maryland | 1 | $89.9 million |
| Miscellaneous Foreign Awardees | 321 | $7.9 million | |
| Ho Chi Minh City HIV/AIDS Association | 4 | $673,404 | |
| Tamra for Social Development Organization (TDS) | 3 | $638,998 | |
| National Empowerment Network of People Living with HIV / AIDS (Nephak) | 3 | $513,403 |
Applying now
This notice no longer takes applications. Apply under the newer notice, DFOP0017890, which is open now.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is 2022-PECO-002 still open?
No. It closed on June 24, 2022. A newer notice is open: DFOP0017890, closes February 14, 2027 (99 days left).
Who can apply for PEPFAR Ethiopia Community-Led Monitoring (CLM) Activities?
U.S. Mission to Ethiopia accepted applications from the applicants described in the notice. The notice adds further conditions, so read its eligibility section.
What is the deadline for PEPFAR Ethiopia Community-Led Monitoring (CLM) Activities?
Closed June 24, 2022. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $24,999 each. About $300,000 in total across about 12 awards.
Who has won The U.S. President's Emergency Plan for AIDS Relief Programs grants before?
The largest recipients over five fiscal years were The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Miscellaneous Foreign Awardees, Ho Chi Minh City HIV/AIDS Association. The program made 794 awards worth $117 million in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)